Speech-Language Pathologists in Valmeyer, IL Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Mrs. Stephanie Stella Hawn, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 S Cedar Bluff Dr, Valmeyer, IL 62295 Phone: 618-935-2100 |
News Archive
Biological clock affects the patterns of heart-rate control in healthy individuals
In a newly reported, first-ever finding, physicists from Boston University and physiologists from Boston's Brigham and Women's Hospital (BWH) have found that the body's biological clock affects the patterns of heart-rate control in healthy individuals independent of sleep/wake cycle or other behavior influences.
FDA and FSIS announce joint public meeting to prevent foodborne illness
A joint public meeting focused on improving the system for tracing of food products and ingredients that are causing illness outbreaks or presenting other risks to the health of consumers was announced today by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services and the Food Safety and Inspection Service (FSIS) of the U.S. Department of Agriculture (USDA).
Electronic cigarettes and smoking cessation: an interview with Professor Peter Hajek
The electronic cigarette has been invented by Chinese pharmacist Hon Lik in 2003. The rise in electronic cigarettes (EC) popularity was initially a grass root phenomenon. EC are estimated to be at least 95% safer than cigarettes and they appeal to smokers who cannot or do not want to stop smoking, but who want to reduce the risks smoking poses to their health.
Orthopaedic Associates of Michigan to partake in new Extremity Trauma Clinical Research Consortium
Orthopaedic Associates of Michigan is one of 12 clinical centers selected to participate in a newly established Extremity Trauma Clinical Research Consortium, funded by the Department of Defense and coordinated by the Research Center at the Johns Hopkins Bloomberg School of Public Health.
Study: Ipilimumab with VEGF inhibitors may be potential option for melanoma patients
Among patients with advanced melanoma, presence of higher levels of the protein vascular endothelial growth factor (VEGF) in blood was associated with poor response to treatment with the immunotherapy ipilimumab, according to a study published in Cancer Immunology Research, a journal of the American Association for Cancer Research.
› Verified 6 days ago